Page last updated: 2024-09-02

morpholinoanthracycline mx2 and Anticipatory Vomiting

morpholinoanthracycline mx2 has been researched along with Anticipatory Vomiting in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hiraoka, A; Kuraishi, Y; Ogawa, M; Okabe, K; Sampi, K; Takemoto, Y; Tamura, K	1

Trials

1 trial(s) available for morpholinoanthracycline mx2 and Anticipatory Vomiting

Article	Year
[Pilot late phase II study of KRN8602 (MX2), a novel anthracycline derivative, for acute leukemia--a dose finding study in combination]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:1 Topics: Adult; Aged; Anorexia; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carubicin; Cytarabine; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine; Vomiting, Anticipatory	1999

Article

Year

[Pilot late phase II study of KRN8602 (MX2), a novel anthracycline derivative, for acute leukemia--a dose finding study in combination].

Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:1

Topics: Adult; Aged; Anorexia; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carubicin; Cytarabine; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine; Vomiting, Anticipatory

1999